US 12,144,795 B2
Cannabidiol compositions having modified cannabinoid profiles
Daniel M. Hallow, Bishop, GA (US); Jun He, Watkinsville, GA (US); Mark C. Dobish, Watkinsville, GA (US); Denis Petrovic, Schaffhausen (CH); and Gnel Mkrtchyan, Watkinsville, GA (US)
Assigned to PURISYS LLC, Athens, GA (US)
Appl. No. 17/273,643
Filed by PURISYS LLC, Athens, GA (US)
PCT Filed Sep. 5, 2019, PCT No. PCT/US2019/049810
§ 371(c)(1), (2) Date Mar. 4, 2021,
PCT Pub. No. WO2020/051371, PCT Pub. Date Mar. 12, 2020.
Claims priority of provisional application 62/727,442, filed on Sep. 5, 2018.
Claims priority of provisional application 62/882,177, filed on Aug. 2, 2019.
Prior Publication US 2022/0218651 A1, Jul. 14, 2022
Int. Cl. A61K 31/352 (2006.01); A61K 31/05 (2006.01)
CPC A61K 31/352 (2013.01) [A61K 31/05 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A composition comprising cannabidiol and delta-9-tetrahydrocannabinol, wherein said delta-9-tetrahydrocannabinol is present in an amount less than 10 ppm.